APOA1 and atherosclerosis: In earlier work developing EC-targeted gene therapy for atherosclerosis, we showed that EC overexpression of apolipoprotein AI (APOAI)—using an expression cassette containing the cytomegalovirus (CMV) immediate early promoter—can slow or reverse atherosclerosis in hyperlipidemic rabbits8–10.